drugset / Trial / NCT07662759

[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

NCT07662759

Phase 3 Recruiting 188 enrolled Kukje Pharma
RandomizedParallel-groupSingle-blindTreatment

Summary

\[KJ-TFC-005\] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Timeline

Start
2025-12-09
Primary completion
2027-03
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject TFC-003 Unknown Topical
Comparator TFC-003-R1 Unknown Topical
Comparator TFC-003-R2 Unknown Topical
Comparator TFC-003-R3 Unknown Topical